Company Filing History:
Years Active: 2012-2016
Title: Marko Ahlmark: Innovator in Pharmaceutical Compounds
Introduction
Marko Ahlmark is a notable inventor based in Espoo, Finland. He has made significant contributions to the field of pharmaceutical compounds, particularly in the area of enzyme inhibition. With a total of 2 patents to his name, Ahlmark's work has the potential to impact various therapeutic applications.
Latest Patents
Ahlmark's latest patents focus on catechol O-methyltransferase (COMT) activity inhibiting compounds. These compounds, defined by specific formulas, exhibit COMT enzyme inhibiting activity, making them useful as COMT inhibitors. His patents also disclose methods of treatment and pharmaceutical dosage forms that utilize these innovative compounds.
Career Highlights
Marko Ahlmark is associated with Orion Corporation, a prominent company in the pharmaceutical industry. His work at Orion has allowed him to explore and develop new therapeutic solutions that address critical health issues.
Collaborations
Ahlmark has collaborated with esteemed colleagues such as Anne M Luiro and Jarmo J Pystynen. These partnerships have fostered a collaborative environment that enhances the innovation process within the company.
Conclusion
Marko Ahlmark's contributions to the field of pharmaceutical compounds demonstrate his commitment to advancing medical science. His innovative patents and collaborations position him as a key figure in the development of new therapeutic agents.